A global trial reveals tirzepatide helps people lose more weight faster than semaglutide. This breakthrough could change ...

Frier Levitt will host a May 15 webinar on legal risks, compounding regulations and market trends impacting GLP-1 prescribers ...

Sharon Osbourne previously opened up about a worrying ‘side effect’ she had suffered after using Ozempic. The former The X ...

Novo Nordisk is doubling down on its oral drug strategy for obesity with a new partnership worth up to $2.2bn with Septerna.

Gill Foster, 58, tipped the scales at 17st 10lb when she decided to start Mounjaro injections with NHS-backed healthy eating ...

Individualized ocular characteristics should be considered before starting GLP-1 RA therapies for weight loss and diabetes ...

Tirzepatide is now approved for the treatment of obstructive sleep apnea, highlighting the drug class' potential in sleep ...

A digital obesity clinic, Embla, is associated with 16.7% weight loss over 64 weeks, matching previous semaglutide trial ...

In SELECT, semaglutide was associated with a 41% reduction in major CV events within 6 months — ie, before weight loss or ...

Limited effectiveness, weight regain, and high prevalence of adverse events are the three key limitations of ...

New research reveals that semaglutide significantly improves liver health in MASH patients. A new study published in the New ...

New animal research being presented at this year's European Congress on Obesity (ECO) in Malaga, Spain (11-14 May), reveals ...